Clinical Impact of Remdesivir in Moderate COVID-19 Unclear
Significant difference seen in clinical status versus usual care for five-day, but not 10-day, course
Nonopioid Pain Protocol Feasible After Sports Orthopedic Surgery
45 percent of patients did not require opioids for management of postoperative pain
Adolescent Vaccinations Decreased During COVID-19 Pandemic
Decrease could offset increased coverage noted from 2018 to 2019 in HPV vaccination, MenACWY
ACIP Issues Recommendations for 2020 to 2021 Flu Vaccination
Components of influenza vaccines updated for 2020-2021; two new vaccine options available for seniors
Extract From Deadly Plant Touted as COVID-19 Cure
Scientists warn that ingesting even a tiny bit of the toxic shrub from which the compound is extracted can be deadly
White House Blocks FDA’s Power to Regulate Lab Tests
FDA staunchly opposes the change, arguing that such authority is critical during a public health emergency
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Short-Term PrEP Feasible for Men at Risk for HIV on Vacation
High levels of medication adherence observed; many interested in transitioning to long-term PrEP
Longer Bisphosphonate Use May Up Atypical Femur Fracture Risk
Rapid decline in atypical fracture risk seen when bisphosphonate discontinued in women ≥50 years
Evinacumab Cuts LDL-C Level in Familial Hypercholesterolemia
LDL-C down at week 24 with evinacumab versus placebo in homozygous familial hypercholesterolemia
